tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Zynerba Pharmaceuticals's activity chart (see below) currently has 62 price targets and 56 ratings on display.
Analysts average stock forecasts to be materialized ratio is 15.19% with an average time for these price targets to be met of 95.87 days.
Most recent stock forecast was given by from CANACCORD on 16-Aug-2023. First documented stock forecast 31-Aug-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Apr-2019
$1.11
$-0.19 (-14.62%)
3 years 1 months 19 days ago
(16-Aug-2023)
0/6 (0%)
$-0.18 (-13.95%)
Buy Since 07-Oct-2016
$23
3 years 1 months 20 days ago
(15-Aug-2023)
0/2 (0%)
$11.13 (93.77%)
Buy Since 14-Nov-2017
$8
5 years 2 months 3 days ago
(02-Aug-2021)
2/9 (22.22%)
$3.99 (99.50%)
113
Buy Since 31-Dec-2019
$7.25
$5.95 (457.69%)
$8.5
5 years 6 months 25 days ago
(10-Mar-2021)
1/4 (25%)
$2.91 (67.05%)
225
Buy Since 05-Jul-2018
$9
$7.7 (592.31%)
5 years 9 months 14 days ago
(21-Dec-2020)
0/4 (0%)
$5.56 (161.63%)
What is ZYNE (Zynerba Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ZYNE (Zynerba Pharmaceuticals)?
Which analyst has the most public recommendations on ZYNE (Zynerba Pharmaceuticals)?
Which analyst is the currently most bullish on ZYNE (Zynerba Pharmaceuticals)?
Which analyst is the currently most reserved on ZYNE (Zynerba Pharmaceuticals)?
